| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A call for an Africa-centric health research ethics framework: a way forward for shaping global health research
|
Fallah, Mosoka Papa
|
|
|
13 |
4 |
p. e616-e617
|
article
|
| 2 |
Advancing maternal and perinatal health through clinical trials: key insights from a WHO global consultation
|
Dey, Teesta
|
|
|
13 |
4 |
p. e740-e748
|
article
|
| 3 |
Announcing the Lancet Global Health Commission on artificial intelligence (AI) and HIV: leveraging AI for equitable and sustainable impact
|
Reid, Michael J A
|
|
|
13 |
4 |
p. e611-e612
|
article
|
| 4 |
A rapid facility-level assessment of oxygen systems in 39 low-income and middle-income countries: a cross-sectional study
|
Ijaz, Nadir
|
|
|
13 |
4 |
p. e646-e655
|
article
|
| 5 |
A roadmap for fostering timely regulatory and ethics approvals of international clinical trials in support of global health research systems
|
Cavaleri, Marco
|
|
|
13 |
4 |
p. e769-e777
|
article
|
| 6 |
Better engagement, better evidence: working in partnership with patients, the public, and communities in clinical trials with involvement and good participatory practice
|
Gobat, Nina
|
|
|
13 |
4 |
p. e716-e731
|
article
|
| 7 |
Correction to Lancet Glob Health 2025; 13: e528–84
|
|
|
|
13 |
4 |
p. e625
|
article
|
| 8 |
Correction to Lancet Glob Health 2025; 13: e345–54
|
|
|
|
13 |
4 |
p. e625
|
article
|
| 9 |
Cost-effectiveness of intrapartum azithromycin to prevent maternal infection, sepsis, or death in low-income and middle-income countries: a modelling analysis of data from a randomised, multicentre, placebo-controlled trial
|
Patterson, Jackie K
|
|
|
13 |
4 |
p. e679-e688
|
article
|
| 10 |
Democratising clinical trials research to strengthen primary health care
|
Butler, Christopher C
|
|
|
13 |
4 |
p. e749-e758
|
article
|
| 11 |
Effectiveness of intrapartum azithromycin to prevent infections in planned vaginal births in low-income and middle-income countries: a post-hoc analysis of data from a multicentre, randomised, double-blind, placebo-controlled trial
|
Carlo, Waldemar A
|
|
|
13 |
4 |
p. e689-e697
|
article
|
| 12 |
Eliminate prescribers' uncertainty to catalyse the impact of vaccines on antibiotic use
|
Ingelbeen, Brecht
|
|
|
13 |
4 |
p. e621
|
article
|
| 13 |
Emerging resistance to dolutegravir: implications for the treatment and prevention programme in South Africa
|
Hunt, Gillian
|
|
|
13 |
4 |
p. e606-e607
|
article
|
| 14 |
Enhanced support for adherence to rheumatic heart disease prophylaxis for children in the public health system in Uganda (CAMPS): a pragmatic randomised trial
|
de Loizaga, Sarah
|
|
|
13 |
4 |
p. e707-e715
|
article
|
| 15 |
Epilepsy in the Indigenous peoples in Canada, Australia, New Zealand, and the USA: a systematic scoping review
|
Keenan, Ngaire F
|
|
|
13 |
4 |
p. e656-e668
|
article
|
| 16 |
Global and regional causes of maternal deaths 2009–20: a WHO systematic analysis
|
Cresswell, Jenny A
|
|
|
13 |
4 |
p. e626-e634
|
article
|
| 17 |
Improving the clinical trial environment and infrastructure: moving from global resolution to action
|
Moorthy, Vasee
|
|
|
13 |
4 |
p. e608-e610
|
article
|
| 18 |
Indonesia's first nationwide health screening programme
|
Nur, Aqsha
|
|
|
13 |
4 |
p. e620
|
article
|
| 19 |
Injury: a neglected global health challenge in low-income and middle-income countries
|
Graham, Simon Matthew
|
|
|
13 |
4 |
p. e613-e615
|
article
|
| 20 |
Patient outcomes after surgery in 17 Latin American countries (LASOS): a 7 day prospective cohort study
|
|
|
|
13 |
4 |
p. e635-e645
|
article
|
| 21 |
Predicted dolutegravir resistance in people living with HIV in South Africa during 2020–35: a modelling study
|
Loosli, Tom
|
|
|
13 |
4 |
p. e698-e706
|
article
|
| 22 |
Redefining implementation science for global health decolonisation
|
The Lancet Global Health,
|
|
|
13 |
4 |
p. e599
|
article
|
| 23 |
Reporting summary results in clinical trial registries: updated guidance from WHO
|
Chan, An-Wen
|
|
|
13 |
4 |
p. e759-e768
|
article
|
| 24 |
Strengthening the paediatric clinical trial ecosystem to better inform policy and programmes
|
Berkley, James A
|
|
|
13 |
4 |
p. e732-e739
|
article
|
| 25 |
The coming of age of in-country laboratory testing for Ebola virus disease in Uganda
|
Wayengera, Misaki
|
|
|
13 |
4 |
p. e624
|
article
|
| 26 |
The devastating impact of the Taliban's ban on midwifery and nursing schools
|
Majrooh, Wahid
|
|
|
13 |
4 |
p. e622-e623
|
article
|
| 27 |
The effect of a social network-based intervention to promote HIV testing and linkage to HIV services among fishermen in Kenya: a cluster-randomised trial
|
Camlin, Carol S
|
|
|
13 |
4 |
p. e669-e678
|
article
|
| 28 |
The promise of antibiotic-led reduction in maternal infection
|
Shakoor, Sadia
|
|
|
13 |
4 |
p. e604-e605
|
article
|
| 29 |
Three-dose immunogenicity of the type 2 novel oral poliovirus vaccine in a campaign setting in Tajikistan: a follow-up study
|
Mirzoev, Azamdzhon
|
|
|
13 |
4 |
p. e618-e619
|
article
|
| 30 |
Towards equity: the unfinished crisis of medical oxygen
|
Falade, Adegoke G
|
|
|
13 |
4 |
p. e602-e603
|
article
|
| 31 |
Urgent and decisive action needed in maternal morbidity and mortality to prevent stagnation in progress
|
Costa, Maria Laura
|
|
|
13 |
4 |
p. e600-e601
|
article
|
Journal description